Here are Thursday’s biggest calls on Wall Street: Morgan Stanley reiterates Broadcom as overweight Morgan Stanley raised its price target on Broadcom to $502 per share from $485 following earnings. “Very strong results amid even higher expectations – but the growth trend remains very strong. PT up to $502, reiterate OW.” Jefferies upgrades RTX to buy from hold Jefferies said it likes the company’s free-cash flow. ” RTX is home to leading franchises across Aerospace (47% of sales) and Defense (53% of sales), with meaningful growth runway from marquee competitive positions & market growth/budget support.” Wolfe initiates FedEx Freight as outperform Wolfe said it sees “material growth.” “We’re launching coverage of FDX Freight with an Outperform rating following its spin from FDX earlier this week. We expect material EPS growth the next few years with company-specific pricing/margin opportunities and an improving fundamental backdrop for all the LTLs.” Macquarie downgrades Broadcom to neutral from outperform The firm downgraded the stock following earnings due to concerns about Alphabet insourcing. “Broadcom was previously the only vendor in Google’s supply chain. However, Google is now working with MediaTek and developing in-house capabilities.” Bank of America reiterates Alphabet as buy The firm said it’s sticking with Alphabet f ollowing its capital raise earlier this week. “We maintain our Buy rating. The Street expects 2027 capex of $241bn and $16bn in positive FCF, and in our view, additional raise could suggest higher capex in 2026 to meet additional demand, or 2027 capex at $270bn+.” Wells Fargo reiterates Microsoft as overweight Wells said it has increased confidence in the stock. “Building on our Day 1 takes (here), we spent time gathering feedback inc a 20 customer survey. We come away w/ inc confidence around MSFT’s AI platform strategy & note copilot feedback & adoption trends are now moving in a more positive direction.” Mizuho reiterates Nvidia as outperform Mizuho said Nvidia is well positioned in the optical networking space. “We remain bullish on the optical/networking market, seeing continued networking innovations, and continue to see upside in our coverage, including CRDO, LITE and NVDA.” Guggenheim initiates Opus Genetics as buy Guggenheim said the stock has plenty of upside. “We are initiating coverage on Opus Genetics (IRD) with a Buy rating and $16 PT.” Benchmark initiates CoStar Group as buy Benchmark said investors should buy the dip in the real estate tech company. “We initiate CoStar Group with a Buy rating and $45 price target.” Bernstein initiates TeraWulf and Cipher Digital as outperform Bernstein said the bitcoin miners are “stand outs.” “We are initiating coverage on TeraWulf ( WULF) and Cipher Digital ( CIFR) with an Outperform rating. WULF and CIFR stand out for their active multi-GW power development pipeline, strong order book (~$24Bn) with hyperscaler sponsorship and a capital-light lease model leading to a rapid AI-revenue ramp up.” Citi reiterates Oracle as buy Citi raised its price target on the stock to $330 per share from $320. “While investor concerns linger on financing/execution of capacity buildouts, we believe ORCL remains on track to deliver one of the strongest revenue/EPS accelerations in tech as large AI contracts ramp.” BTIG upgrades Medtronic to buy from neutral BTIG said it sees consistent growth. “We are upgrading MDT to Buy and establishing a $90 PT based on 14x our 12-24 mo. EPS est., a discount to peers.” Read more. KeyBanc upgrades Murphy Oil to overweight from sector weight Key said it likes the company’s exposure to higher oil pricing. ” Murphy presents exposure to higher oil prices (50% of 2026E production is oil; none is hedged) and idiosyncratic Vietnam catalysts.” Goldman Sachs upgrades Expro Group Holdings to buy from neutral Goldman said it likes the energy services company’s exposure to geopolitics. “Second, we are upgrading XPRO to Buy from Neutral, given it has a very similar geographical mix as larger international exposed peers and has meaningfully lagged (-15% vs peers +4%) since the start of the conflict in the Middle East.” KBW upgrades Essent Group to outperform from market perform KBW said shares of the mortgage insurance company are compelling. “Mortgage Insurer share performance has ranged between +4% and -15% YTD, with meaningful weakness post 1Q earnings. We think the recent weakness has primarily been on credit concerns as 1Q delinquencies came in modestly higher than expectations. The shares of several names are trading below book value, with ESNT t he cheapest at 93% of 1Q TBV.” Morgan Stanley reiterates CrowdStrike as overweight Morgan Stanley raised its price target on the stock to $690 per share from $610. “CRWD’s FQ1 beat expectations across the board, but the bigger story was $52mm raise to FY27 NNARR [net annual recurring revenue] guidance driven by accelerating AI demand, record pipeline, and broad platform strength.” Bernstein reiterates Netflix as outperform Bernstein said the stock is a “durable engine.” “We believe Netflix can roughly double EPS from ~$3.15 (consensus EPS ex-breakup fee received from WBD) in 2026 to > $6 by 2030.” JPMorgan upgrades Venture Global to overweight from neutral JPMorgan said the company can benefit from geopolitical instability. “Ultimately, we see these geopolitical developments playing into VG’s s trengths, leading to outsized margin capture and aiding medium- and long-term contracting.” William Blair upgrades Karat Packaging to outperform from market perform The firm said in its upgrade o f Karat that the stock is well positioned for share gains. “We are upgrading our rating to Outperform from Market Perform after management sounded optimistic on share gains, gross margin recovery, and online sales acceleration (higher margin).” MoffettNathanson reiterates Apple as neutral MoffettNathanson said it’s cautious heading in to Apple’s Worldwide Developer’s Conference next week. “The set-up as we head into WWDC 2026 is eerily similar to that of 2024, when optimism about all things AI was (more than) fully priced into Apple’s shares.” Bank of America upgrades UnitedHealth to buy from neutral The firm said the stock is too attractive to ignore. “We are upgrading UNH to Buy as improving medical cost trends and supportive near- term data points set up a favorable 2Q earnings setup and attractive risk/reward.”
